SMC6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.415400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.775200E-01
Normal-vs-Stage2
5.366000E-01
Normal-vs-Stage3
3.494200E-01
Normal-vs-Stage4
7.323400E-01
Stage1-vs-Stage2
6.065000E-01
Stage1-vs-Stage3
2.974600E-01
Stage1-vs-Stage4
1.695170E-01
Stage2-vs-Stage3
1.569020E-01
Stage2-vs-Stage4
2.389400E-01
Stage3-vs-Stage4
4.688000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.481400E-01
Normal-vs-AfricanAmerican
3.680400E-01
Normal-vs-Asian
4.174400E-01
Caucasian-vs-AfricanAmerican
9.820600E-01
Caucasian-vs-Asian
2.095200E-01
AfricanAmerican-vs-Asian
3.206800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.882770E-01
Normal-vs-Female
5.310200E-01
Male-vs-Female
7.291000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.339400E-01
Normal-vs-Age(41-60Yrs)
5.913200E-01
Normal-vs-Age(61-80Yrs)
1.578770E-01
Normal-vs-Age(81-100Yrs)
5.253600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.080400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.119400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.560400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.274600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.268600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.919600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.053800E-01
Normal-vs-Daily Drinker
4.584000E-01
Normal-vs-Weekly Drinker
2.212200E-01
Normal-vs-Occasional Drinker
5.227200E-01
Normal-vs-Social Drinker
3.158800E-01
Non Drinker-vs-Daily Drinker
5.796400E-01
Non Drinker-vs-Weekly Drinker
9.227400E-01
Non Drinker-vs-Occasional Drinker
8.491600E-01
Non Drinker-vs-Social Drinker
4.366800E-01
Daily Drinker-vs-Weekly Drinker
6.159800E-01
Daily Drinker-vs-Occasional Drinker
5.003600E-01
Daily Drinker-vs-Social Drinker
2.755400E-01
Weekly Drinker-vs-Occasional Drinker
9.549800E-01
Weekly Drinker-vs-Social Drinker
6.029800E-01
Occasional Drinker-vs-Social Drinker
5.550200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.264400E-01
Normal-vs-Grade 2
2.165500E-02
Normal-vs-Grade 3
3.788000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.451400E-01
Grade 1-vs-Grade 3
3.859000E-01
Grade 1-vs-Grade 4
3.264400E-01
Grade 2-vs-Grade 3
2.112800E-01
Grade 2-vs-Grade 4
2.165500E-02
Grade 3-vs-Grade 4
3.788000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.481400E-01
Normal-vs-NonDiabetic
5.087000E-01
Diabetic-vs-NonDiabetic
5.991200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.802600E-01
Normal-vs-NoPancreatitis
5.289600E-01
Pancreatitis-vs-NoPancreatitis
6.416000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.984200E-01
Normal-vs-N1
5.355000E-01
N0-vs-N1
6.392600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.577600E-01
Normal-vs-TP53-NonMutant
2.699800E-01
TP53-Mutant-vs-TP53-NonMutant
8.956400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
